EMEA-001516-PIP01-13

Key facts

Active substance
Enalapril (maleate)
Therapeutic area
Cardiovascular diseases
Decision number
P/0112/2014
PIP number
EMEA-001516-PIP01-13
Pharmaceutical form(s)
  • Tablet for oral suspension
  • Orodispersible film
Condition(s) / indication(s)
Treatment of hypertension
Route(s) of administration
Oral use
Contact for public enquiries
Pharmathen S.A.
Greece
E-mail: mkalovidouri@pharmathen.com
Tel. +30 2106 604354
 
Decision type
P: decision agreeing on a investigation plan, with or without partial waiver(s) and or deferral(s)

Decision

How useful was this page?

Add your rating